Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review
| Autor: | Megan M. Kelly, Shane W. Kraus, Steven D. Shirk, Nitigna Desai, Victoria Ameral, Joseph R. Houchins, Kendra Pugh, Erin D. Reilly |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Narcotic Antagonists
(+)-Naloxone Injections Intramuscular Naltrexone Chart review Buprenorphine/naloxone medicine Humans Prospective Studies Retrospective Studies Veterans business.industry Opioid use disorder medicine.disease Opioid-Related Disorders Buprenorphine Psychiatry and Mental health Anesthesia Delayed-Action Preparations Buprenorphine Naloxone Drug Combination Extended release business human activities medicine.drug |
| Zdroj: | Journal of dual diagnosis. 17(3) |
| ISSN: | 1550-4271 |
| Popis: | Previous research has demonstrated the effectiveness of both extended-release injectable naltrexone (XR-NTX) and buprenorphine/naloxone (BUP-NX) in the treatment of opioid use disorder (OUD). However, studies using real-world samples with multiple medical and psychiatric comorbidities are lacking. The study's primary aims were to: (1) compare clinical presentations in an inclusive sample of OUD-diagnosed US military veterans receiving XR-NTX and BUP-NX, and (2) investigate differences in 90-day treatment outcomes between these two groups. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|